MedTrace Logo

SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting

NCT04519372 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4099

Last updated 2021-05-18

No results posted yet for this study

Summary

The proportion of asymptomatic carriers of SARS-CoV-2 remains elusive, so the potential benefit of systematic screening during the SARS-CoV-2-pandemic is controversial. We investigate the proportion of asymptomatic inpatients who were identified by systematic screening for SARS-CoV-2 upon hospital admission.

Adult patients admitted to the University Hospital Basel from 01.04.-14.06.2020 were routinely tested for SARS-CoV-2 within 72 hours of admission by nasopharyngeal swabs.

Each patient screened during the study period was retrospectively classified symptomatic or asymptomatic for COVID-19 based on medical chart review.

Conditions

Interventions

DIAGNOSTIC_TEST

Testing for SARS-CoV-2

All Patients admitted to the hospital were routinely tested for SARS-CoV-2 within 72 hours of admission by nasopharyngeal swabs.

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Sarah Tschudin-Sutter, Prof. Dr. MD · University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-06-14
Completion
2021-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04519372 on ClinicalTrials.gov